Recent RNXT News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 08:10:23 PM
- RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians • GlobeNewswire Inc. • 09/25/2024 12:30:00 PM
- RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer • GlobeNewswire Inc. • 09/19/2024 12:30:00 PM
- RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New York • GlobeNewswire Inc. • 08/27/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:05:17 PM
- RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial • GlobeNewswire Inc. • 08/14/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 09:03:54 PM
- RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist® • GlobeNewswire Inc. • 07/31/2024 12:30:00 PM
- RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist® • GlobeNewswire Inc. • 07/08/2024 12:30:00 PM
- University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial • GlobeNewswire Inc. • 06/26/2024 12:30:00 PM
- RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships • GlobeNewswire Inc. • 06/10/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:41:02 PM
- RenovoRx CEO Issues Update Letter to Shareholders • Business Wire • 05/30/2024 12:30:00 PM
- Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment Delivery • Business Wire • 05/21/2024 01:00:00 PM
- RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024 • Business Wire • 05/14/2024 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/13/2024 04:15:43 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:21:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/10/2024 08:50:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/10/2024 08:47:08 PM
- RenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024 • Business Wire • 05/02/2024 01:00:00 PM
- RenovoRx Regains Compliance with Nasdaq Stockholders’ Equity Requirement • Business Wire • 04/18/2024 12:30:00 PM
- RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting • Business Wire • 04/16/2024 12:30:00 PM
- RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026 • Business Wire • 04/15/2024 12:00:00 PM
- RenovoRx Announces $11.1 Million at Market Private Placement • Business Wire • 04/08/2024 12:30:00 PM
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • Oct 1, 2024 7:00 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM